Logo

tumor sequencing

Myriad Genetics, Intermountain Precision Genomics Obtain NY Certification for Solid Tumor Testing

The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.

Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test

The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.

Genome Insight, Seoul National University Hospital Collaborate on WGS Study of Pediatric Cancer Dx

Caris Life Sciences Adds Everything Genetic as UK Distributor

Everything Genetic will distribute Caris Life Sciences' Molecular Intelligence Tumor Seek NGS-based tumor profiling service in the UK.

Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients

Tempus' xT platform will be used to identify patients likely to match for a trial assessing the efficacy of genetically informed treatments in certain pediatric cancers.

Jul 12, 2022

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

Jun 9, 2022

Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients

Jun 1, 2022

Avera Health, Sema4 Launch Five-Year Precision Oncology Study

May 18, 2022

Illumina, Allegheny Health Network Collaborate on Study of Cancer Genomic Profiling

May 4, 2022

NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel

Aug 9, 2021

Single Metastatic Cancer Genome Analysis Appears Sufficient to ID Biomarkers, Treatment Options

Jul 29, 2021

Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes, Treatment Clues

Jun 4, 2021

Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease

Apr 1, 2021

Tumor-Only Sequencing for TMB Measurements May Inflate Scores in Black Patients
Premium

Mar 23, 2021

Caris-Led Team Searches for Clues to Poor COVID-19 Outcomes in Cancer Patients' Transcriptome Data
Premium

Feb 26, 2021

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year
Premium

Feb 5, 2021

Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering
Premium

Dec 9, 2020

Appendiceal Cancer Sequences Suggest Distinct Mutation Patterns in Early-, Late-Onset Cases

Nov 10, 2020

BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research

Oct 8, 2020

Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants

Sep 1, 2020

GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx in Australia

Aug 13, 2020

Triple-Negative Breast Cancer Treatment Hints Drawn From Single-Cell Study

Jul 15, 2020

Patient Education Project Identifies Need for Consistent Terms in Cancer Testing
Premium

Jun 15, 2020

Dante Labs, Cambridge Cancer Genomics, Nonacus Collaborate to Build Tumor Profiling Service

May 1, 2020

Targeted Drugs Suggested by Molecular Tumor Board Shrunk Tumors in Two-Thirds of Lung Cancer Patients